Cerinib 150Mg

0.00$

CERINIB is an oral medication containing 150mg of Ceritinib, prescribed primarily for the treatment of non-small cell lung cancer (NSCLC). As a tyrosine kinase inhibitor, Ceritinib targets specific proteins crucial for cancer cell growth and proliferation. It works by inhibiting these proteins, thereby impeding tumor progression.

Add to wishlist
Share

    A powerful prescription drug called cerinib 150mg is used to treat particular forms of non-small cell lung cancer (NSCLC). Patients whose cancer cells test positive for an aberrant anaplastic lymphoma kinase (ALK) gene benefit most from it. Cerinib 150mg, also referred to by its generic name ceritinib, is a highly precisely manufactured member of the ALK inhibitor class of targeted cancer treatments. For patients whose tumors have relapsed after first therapies or are resistant to conventional chemotherapy, this medication gives new hope.


    Mechanism of Action

    Cerinib 150mg inhibits the function of the ALK protein in cancer cells by selectively targeting it. A genetic mutation in ALK-positive NSCLC results in aberrant ALK protein, which promotes the development and metastasis of malignant cells. By attaching itself to this changed protein and blocking its signaling route, ceritinib efficiently prevents the growth, multiplication, and dissemination of cancer cells. Because of this focused strategy, the medication can target cancer cells while having little effect on healthy, normal cells.


    Indications and Usage

    The majority of patients with ALK-positive metastatic non-small cell lung cancer (NSCLC) are treated cerimib 150 mg. It is especially used to people who:

     

    are intolerant to crizotinib, another ALK inhibitor, or have demonstrated illness progression while taking it.

     

    have tested positive for ALK gene rearrangements but have not previously undergone ALK-targeted treatment.

     

    Cerinib is only used in people whose tumors express the ALK abnormalities because it is a targeted therapy. Usually, a companion diagnostic test is needed to establish therapy eligibility.


    Dosage and Administration

    Cerinib is normally administered in 150 mg capsules, with a suggested daily dosage of 750 mg taken on an empty stomach. This indicates that a patient typically takes five 150 mg capsules of Cerinib each day.

     

    However, based on tolerance and updated clinical guidelines, recent suggestions can change the dosage to 450 mg with food. Always pay strict attention to the dosage and timing recommendations made by your physician.

     

    Among the crucial factors are:

     

    Every day, take the medication at the same time.

     

    Do not chew or crush the capsules; swallow them whole.

     

    During therapy, stay away from grapefruit and grapefruit juice since they may interact with the drug.


    Side Effects and Safety Profile

    Cerinib 150mg may have adverse effects, just like any other cancer medication. Common side effects include the following, though not everyone experiences them:

     

    Vomiting and feeling queasy

     

    Having diarrhea

     

    Pain in the abdomen

     

    Weariness

     

    Elevated liver enzymes

     

    Diminished appetite

     

    Constipation

     

    The following are more severe side effects that call for prompt medical attention:

     

    severe issues with the liver

     

    Interstitial lung disease, or lung inflammation

     

    Issues with heart rhythm (QT prolongation)

     

    Hyperglycemia, or elevated blood sugar levels

     

    Pancreatitis

     

    For Cerinib medication to be safe and successful, routine monitoring using blood tests, EKGs, and liver function testing is necessary.


    Precautions and Warnings

    Prior to beginning Cerinib 150mg, let your doctor know about:

     

    Any past medical history of pancreatic or liver diseases

     

    Heart issues

     

    Blood sugar problems or diabetes

     

    Being pregnant or intending to get pregnant

     

    Currently using other drugs, either prescription or over-the-counter

     

    If used while pregnant, cerinib may harm the fetus. During treatment and for at least six months following the last dosage, effective contraception should be used. It is not advised to use it during nursing.


    Drug Interactions

    Other medications, especially those that impact liver enzymes, may interact with cerinib. The following medications should be avoided or used carefully:

     

    Antifungal medications, such as ketoconazole

     

    Antibiotics (clarithromycin, for example)

     

    Anticonvulsants

     

    Inhibitors of HIV protease

     

    The Wort of St. John

     

    Before beginning Cerinib, always provide your doctor a full list of all the drugs and supplements you are currently taking.


    Storage and Handling

    Cerinib 150mg capsules should be kept out of direct sunlight and at room temperature (20°C to 25°C) in a firmly sealed container. Keep out of children’s and pets’ reach. The drug should not be used past the date of expiration indicated on the container.


    Conclusion

    For patients with ALK-positive metastatic non-small cell lung cancer (NSCLC), cerinib 150mg provides a highly focused and effective treatment, particularly for those who have not responded to or are unable to tolerate previous courses of therapy. Although there is a chance of adverse effects, results can be greatly enhanced with appropriate monitoring and adherence to medical guidance. Consult your oncologist to determine whether Cerinib is a suitable therapy choice if you or a loved one has ALK-positive lung cancer.


    Order Now At Mdx Pharma bd….

    To order from MDX Pharma BD, visit their website at https://mdxpharmabd.com, where you can browse products and place orders online. For inquiries or orders via email, contact emedicarepharma@gmail.com. Alternatively, call (+88) 01929123476. Their address is 29, Abdullahpur, Uttara, Dhaka-1230, Bangladesh.

     

    1. What is the purpose of 150 mg of ceritinib?
    Patients with metastatic (cancer that has spread) non-small cell lung cancer who have a particular kind of aberrant anaplastic lymphoma kinase (ALK) gene are treated with ceritanib. The presence of this gene will be tested for by your physician. Ceritinib is a substance that fights cancer.

     

    2. What is ceritinib’s method of action?
    ALK, IGF-1R, insulin receptor (InsR), and ROS1 are among the RTKs that ceritinib is a strong and specific inhibitor of. It prevents the growth of cancer cells that are dependent on ALK, autophosphorylation of ALK, and ALK-mediated phosphorylation of the downstream signaling molecule STAT3.

     

    3. Does the blood-brain barrier allow ceritinib to pass through?
    Ceritinib also has improved blood-brain barrier penetration. Both individuals who have never had treatment before and those who are resistant to crizotinib can use ceritinib. ASCEND-5 (N = 231) showed that ceritinib was clinically superior to third-line chemotherapy in patients who had previously received both crizotinib and platinum-based chemotherapy.

     

    4. What adverse effects might 150 mg of Ceritinib cause?
    As directed, take Ceritinib. To obtain the most benefit, do as your doctor directs. Diarrhea, feeling or being sick, abdominal discomfort, vomiting, exhaustion (feeling overtired), decreased appetite, and weight loss are some common side effects that you may occasionally experience.

    Product Name

    CERINIB

    Generic Name

    CERINIB

    Formulation

    Oral capsule

    Available Pack Size

    30's

    Available Strength

    150Mg